Entellus Medical acquires Spirox for $81M

Entellus Medical has agreed to acquire Spirox, a maker of the Latera Absorbable Nasal Implant, for $25 million in cash and approximately 3.4 million shares of Entellus common stock worth about $56 million.

“We believe this combination [of Entellus and Spirox] will enhance the near and long-term growth potential of our business and bolster our strategy to deliver less invasive treatment options to ENTs.”tcbmag.com

• 1 source
• tcbmag.comEntellus Unveils $81M Merger Plan with Spirox | Twin Cities BusinessWebsite by Web Publisher PRO, Protected by Bot ShieldJul 7, 2017

Summarized from public sources; check the original articles before acting on it.